Is LUV Stock a Buy, Sell or Hold?
Southwest Airlines (NYSE:LUV) is one of America’s major air transportation…
Sell
42
EHTH Quote, Financials, Valuation and Earnings
Last price:
$6.10
Seasonality move
:
6.98%
Day range:
$6.50 - $6.79
52-week range:
$3.58 - $11.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.37x
P/B ratio:
0.34x
Volume:
123K
Avg. volume:
254.2K
1-year change:
19%
Market cap:
$198.8M
Revenue:
$532.4M
EPS (TTM):
-$1.61
Analysts' Opinion
-
Consensus RatingeHealth has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $10.63, eHealth has an estimated upside of 60.02% from its current price of $6.64.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $9.50 representing 100% downside risk from its current price of $6.64.
Fair Value
-
According to the consensus of 5 analysts, eHealth has 60.02% upside to fair value with a price target of $10.63 per share.
EHTH vs. S&P 500
-
Over the past 5 trading days, eHealth has underperformed the S&P 500 by -6.11% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
eHealth does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
eHealth has grown year-over-year revenues for 1 quarter straight. In the most recent quarter eHealth reported revenues of $315.2M.
Earnings Growth
-
eHealth has grown year-over-year earnings for 1 quarter straight. In the most recent quarter eHealth reported earnings per share of $2.51.
Enterprise value:
185M
EV / Invested capital:
--
Price / LTM sales:
0.37x
EV / EBIT:
6.07x
EV / Revenue:
0.35x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-5.93x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
3.95x
Gross Profit (TTM):
--
Return On Assets:
0.93%
Net Income Margin (TTM):
1.89%
Return On Equity:
1.6%
Return On Invested Capital:
1.44%
Operating Margin:
35.76%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $405.4M | $452.9M | $532.4M | $247.7M | $315.2M | |
| Gross Profit | $403.7M | -- | -- | -- | $313.9M | |
| Operating Income | -$83.1M | -$29.1M | $33M | $59.4M | $112.7M | |
| EBITDA | -$77.7M | $295K | $46.8M | $66.1M | $116.9M | |
| Diluted EPS | -$4.42 | -$2.60 | -$1.61 | $1.27 | $2.51 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $331M | $407.6M | $401.1M | $382.4M | $354.5M | |
| Total Assets | $1B | $1.1B | $1.1B | $1.1B | $1.2B | |
| Current Liabilities | $84.4M | $75.5M | $60.6M | $78.5M | $96M | |
| Total Liabilities | $202.5M | $399.8M | $461.7M | $507.3M | $567M | |
| Total Equity | $837.6M | $749.5M | $651M | $606M | $588.4M | |
| Total Debt | -- | -- | $66.1M | $67.8M | $68.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$26.9M | -$6.7M | -$18.4M | -$33.4M | -$27.7M | |
| Cash From Investing | $25.9M | -$15.9M | -$48.4M | $596K | $8M | |
| Cash From Financing | $63.8M | -$6.2M | -$9.7M | -$3.6M | -$5M | |
| Free Cash Flow | -$42.4M | -$17.5M | -$31.2M | -$35.4M | -$31M | |
EHTH
Sector
Market Cap
$198.8M
$622M
Price % of 52-Week High
58.45%
86%
Dividend Yield
0%
1.98%
Shareholder Yield
1.14%
3.69%
1-Year Price Total Return
19%
9.44%
Beta (5-Year)
0.810
0.555
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
55.3%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$6.88
200-day SMA
Buy
Level
$6.15
Bollinger Bands (100)
Sell
Level
5.91 - 9.81
Chaikin Money Flow
Sell
Level
-405.1K
20-day SMA
Sell
Level
$7.43
Relative Strength Index (RSI14)
Sell
Level
30.95
ADX Line
Sell
Level
19.94
Williams %R
Buy
Level
-85.5908
50-day SMA
Sell
Level
$8.90
MACD (12, 26)
Buy
Level
1.84
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Sell
Level
-130.1K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.1316)
Buy
CA Score
(Annual)
Level (-0.0386)
Sell
Beneish M-Score
(Annual)
Level (0.1712)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.8672)
Buy
Piotroski F Score
(Annual)
Level (5)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
Stock Forecast FAQ
In the current month, EHTH has received 1 Buy ratings 4 Hold ratings, and 0 Sell ratings. The EHTH average analyst price target in the past 3 months is $10.63.
-
Where Will eHealth Stock Be In 1 Year?
According to analysts, the consensus estimate is that eHealth share price will rise to $10.63 per share over the next 12 months.
-
What Do Analysts Say About eHealth?
Analysts are divided on their view about eHealth share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that eHealth is a Sell and believe this share price will drop from its current level to $9.50.
-
What Is eHealth's Price Target?
The price target for eHealth over the next 1-year time period is forecast to be $10.63 according to 5 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is EHTH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for eHealth is a Hold. 4 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of EHTH?
You can purchase shares of eHealth via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase eHealth shares.
-
What Is The eHealth Share Price Today?
eHealth was last trading at $6.10 per share. This represents the most recent stock quote for eHealth. Yesterday, eHealth closed at $6.64 per share.
-
How To Buy eHealth Stock Online?
In order to purchase eHealth stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
43
MNPR alert for Apr 3
Monopar Therapeutics [MNPR] is down 7.22% over the past day.
Buy
75
BKTI alert for Apr 3
BK Technologies [BKTI] is down 10.01% over the past day.
Sell
34
SWTX alert for Apr 3
SpringWorks Therapeutics [SWTX] is down 6.02% over the past day.
